Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Waller

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.
BMJ Open|September 3, 2020
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesotheliomaEric Lim, Liz Darlison, John Edwards, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 26, 2020
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesotheliomaIsabelle Opitz, Arnaud Scherpereel, Thierry Berghmans, et al.
Eclinicalmedicine|August 25, 2021
Maintaining safe lung cancer surgery during the COVID-19 pandemic in a global cityStephanie Fraser, Ralitsa Baranowski, Davide Patrini, et al.
Nature Communications|June 8, 2021
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
The Cochrane Database of Systematic Reviews|March 3, 2015
Adjuvant chemotherapy for resected early-stage non-small cell lung cancerSarah Burdett, Jean Pierre Pignon, Jayne Tierney, et al.
The Lancet. Respiratory Medicine|May 13, 2024
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trialEric Lim, David Waller, Kelvin Lau, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.
BMJ Open|September 3, 2020
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesotheliomaEric Lim, Liz Darlison, John Edwards, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 26, 2020
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesotheliomaIsabelle Opitz, Arnaud Scherpereel, Thierry Berghmans, et al.
Eclinicalmedicine|August 25, 2021
Maintaining safe lung cancer surgery during the COVID-19 pandemic in a global cityStephanie Fraser, Ralitsa Baranowski, Davide Patrini, et al.
Nature Communications|June 8, 2021
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
The Cochrane Database of Systematic Reviews|March 3, 2015
Adjuvant chemotherapy for resected early-stage non-small cell lung cancerSarah Burdett, Jean Pierre Pignon, Jayne Tierney, et al.
The Lancet. Respiratory Medicine|May 13, 2024
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trialEric Lim, David Waller, Kelvin Lau, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Pageof 9